BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 8:23:16 AM | Browse: 312 | Download: 974
Publication Name World Journal of Diabetes
Manuscript ID 111698
Country Italy
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Randomized Clinical Trial
Article Title Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial
Manuscript Source Invited Manuscript
All Author List Alfredo Caturano, Vittorio Simeon, Raffaele Galiero, Vincenzo Russo, Luca De Nicola, Paolo Chiodini, Luca Rinaldi, Erica Vetrano, Teresa Salvatore, Caterina Conte, Carlo Acierno, Celestino Sardu, Raffaele Marfella, Roberto Minutolo and Ferdinando C Sasso
ORCID
Author(s) ORCID Number
Alfredo Caturano http://orcid.org/0000-0001-7761-7533
Vincenzo Russo http://orcid.org/0000-0002-9227-0360
Paolo Chiodini http://orcid.org/0000-0003-0139-2264
Luca Rinaldi http://orcid.org/0000-0002-6541-3821
Caterina Conte http://orcid.org/0000-0001-7066-5292
Raffaele Marfella http://orcid.org/0000-0003-3960-9270
Ferdinando C Sasso http://orcid.org/0000-0002-9142-7848
Funding Agency and Grant Number
Funding Agency Grant Number
Ministero dell’ Università e della Ricerca (Italian Ministry of University and Research) No. 2007PSYLRX
Corresponding Author Caterina Conte, Professor, Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, Via di val Cannuta, 247, Rome 00166, Italy. caterina.conte@uniroma5.it
Key Words Type 2 diabetes mellitus; Glycated hemoglobin; Multifactorial intervention; Cardiovascular diseases; Risk factors; Diabetic complications
Core Tip In high-risk patients with type 2 diabetes, achieving a glycated hemoglobin ≤ 7% was associated with fewer cardiovascular events only under standard care conditions, suggesting that the cardiovascular benefit of glycemic control may depend on treatment intensity. In contrast, younger age, female sex, and blood pressure control were more consistent predictors of improved outcomes. Low-density lipoprotein cholesterol control showed a borderline association with reduced mortality in the standard of care group only.
Publish Date 2025-11-14 08:23
Citation

Caturano A, Simeon V, Galiero R, Russo V, De Nicola L, Chiodini P, Rinaldi L, Vetrano E, Salvatore T, Conte C, Acierno C, Sardu C, Marfella R, Minutolo R, Sasso FC. Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial. World J Diabetes 2025; 16(11): 111698

URL https://www.wjgnet.com/1948-9358/full/v16/i11/111698.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i11.111698
Full Article (PDF) WJD-16-111698-with-cover.pdf